MedTrace Logo

Azathioprine in Recurrent Implantation Failure

NCT03498703 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2019-07-24

No results posted yet for this study

Summary

Azathioprine increase pregnancy rate in patients with recurrent implantation failure

Conditions

  • Recurrent Implantation Failure
  • In Vitro Fertilization
  • Intracytoplsmic Sperm Injection

Interventions

DRUG

Azathioprine Pill

Azathioprine increase pregnancy rate in cases with recurrent implantaion failure

DRUG

Placebo Oral Tablet

Placebo tablets

Sponsors & Collaborators

  • Capital Birth Center

    collaborator UNKNOWN

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Ahmed H Salama · Capital Birth Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-25
Primary Completion
2019-07-01
Completion
2019-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03498703 on ClinicalTrials.gov